BioNTech and Moderna

These shares are looking good lately are they linked?

Umm yes, there’s supplying COVID vaccine to many countries. They’ve gone up since J&J vaccine was paused.

2 Likes

I really dont want to be rude, but have you watched the news at least once in the last 6 months? :smile:

4 Likes

:thinking: :+1: Sorry,

1 Like

How do people think these companies will perform post-covid (genuine question)?

2 Likes

I don’t hold positions in either but Moderna is betting big on mRNA therapeutics.

They have treatment for CMV in the pipeline which is massive.

It’s a growth stock - high risk high reward play.

3 Likes

Going up today!

The European Union has reached an agreement to speed up delivery of 50 million more doses of the BioNTech-Pfizer COVID-19 vaccines to boost the continent’s vaccination program. “Those 50 million doses were initially foreseen for delivery in the fourth quarter of 2021. Now they are available in quarter 2,” European Commission President Ursula von der Leyen said in a statement on Wednesday. Johnson & Johnson has delayed its deliveries of vaccines in the EU. U.S. regulatory authorities on Tuesday advised the suspension of those shots after after six women were diagnosed with severe blood clots. The European Medicines Agency is also reviewing those shots. Von der Leyen said the EU is also negotiating with Pfizer-BioNTech for a third contract that will deliver 1.8 billion doses over 2021 to 2023. Production of the vaccines and all essential components will be based in the EU. She added that the EU reached a milestone of 100 million vaccinations as of Wednesday, with more than a quarter are second doses.